Chronic Obstructive Pulmonary Disease Increases the Risk of New-onset Atrial Fibrillation and Mortality of Patients with Atrial Fibrillation
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Although a few previous studies have analyzed the role of reduced lung function in predicting atrial fibrillation (AF), the relationship between the incidence of AF and comorbid chronic obstructive pulmonary disease (COPD) is unclear. We hypothesized that COPD is associated with the occurrence of new-onset AF and clinical outcomes in AF patients. Methods: We analyzed the development of new-onset AF in 501,668 patients without AF and clinical outcomes in 4,541 patients with AF using Korean National Health Insurance Service-National Sample Cohort (NHIS-NSC). Results: Comorbid COPD was found in 4.8% (11,442 of 501,668) of non-AF patients and 18.6% (820 of 4,541) of AF patients. The incidence of AF in COPD patients was significantly higher compared to non-COPD patients (2.6% vs. 0.6%, p<0.001) over the follow-up period (45.5±14.9 months). In a multivariate Cox regression analysis, COPD predicted higher risk of AF independently from other risk factors (HR: 1.41, 95% CI: 1.25-1.60, p<0.001). The all-cause mortality of AF patients with COPD was significantly higher in patients who used b-blockers (20.6% vs 13.1% during follow-up, p<0.008). Multivariate Cox regression analysis showed that COPD is still an independent risk factor for all-cause mortality (HR: 1.25, 95% CI: 1.03-1.51, p=0.022), and stroke (HR: 1.19, 95% CI: 1.00- 1.41, p=0.039). Conclusion: The presence of COPD is an independent risk factor for new-onset AF. COPD is independently associated with all-cause mortality and stroke in AF patients.
Abstract
Background: Although a few previous studies have analyzed the role of reduced lung function in predicting atrial fibrillation (AF), the relationship between the incidence of AF and comorbid chronic obstructive pulmonary disease (COPD) is unclear. We hypothesized that COPD is associated with the occurrence of new-onset AF and clinical outcomes in AF patients. Methods: We analyzed the development of new-onset AF in 501,668 patients without AF and clinical outcomes in 4,541 patients with AF using Korean National Health Insurance Service-National Sample Cohort (NHIS-NSC). Results: Comorbid COPD was found in 4.8% (11,442 of 501,668) of non-AF patients and 18.6% (820 of 4,541) of AF patients. The incidence of AF in COPD patients was significantly higher compared to non-COPD patients (2.6% vs. 0.6%, p<0.001) over the follow-up period (45.5±14.9 months). In a multivariate Cox regression analysis, COPD predicted higher risk of AF independently from other risk factors (HR: 1.41, 95% CI: 1.25-1.60, p<0.001). The all-cause mortality of AF patients with COPD was significantly higher in patients who used b-blockers (20.6% vs 13.1% during follow-up, p<0.008). Multivariate Cox regression analysis showed that COPD is still an independent risk factor for all-cause mortality (HR: 1.25, 95% CI: 1.03-1.51, p=0.022), and stroke (HR: 1.19, 95% CI: 1.00- 1.41, p=0.039). Conclusion: The presence of COPD is an independent risk factor for new-onset AF. COPD is independently associated with all-cause mortality and stroke in AF patients.
참고문헌 (36)
- Heeringa J, "Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study", Eur Heart J, 27, pp.949~953 (2006)
- Benjamin EJ, "Impact of atrial fibrillation on the risk of death: the Framingham heart study", Circulation, 98, pp.946~952 (1998)
- Konecny T, "Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias", Am J Cardiol, 114, pp.272~277 (2014)
- Curkendall SM, "Chronic obstructive pulmonary disease severity and cardiovascular outcomes", Eur J Epidemiol, 21, pp.803~813 (2006)
- Lee J, "Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)
- Kim C, "Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea", Int J Tuberc Lung Dis, 18, pp.737~743 (2014)
- Chen SJ, "Dental scaling and atrial fibrillation : a nationwide cohort study", Int J Cardiol, 168, pp.2300~2303 (2013)
- Chao TF, "Rate-control treatment and mortality in atrial fibrillation", Circulation, 132, pp.1604~1612 (2015)
- Curkendall SM, "Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients", Ann Epidemiol, 16, pp.63~70 (2006)
- Finkelstein J, "Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity", Int J Chron Obstruct Pulmon Dis, 4, pp.337~349 (2009)
- Schneider C, "Chronic obstructive pulmonary disease and the risk of cardiovascular diseases", Eur J Epidemiol, 25, pp.253~260 (2010)
- Sidney S, "COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program", Chest, 128, pp.2068~2075 (2005)
- Fang X, "COPD in China: the burden and importance of proper management", Chest, 139, pp.920~929 (2011)
- Feary JR, "Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care", Thorax, 65, pp.956~962 (2010)
- Sin DD, "Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease", Can J Physiol Pharmacol, 83, pp.8~13 (2005)
- Barnes PJ, "Systemic manifestations and comorbidities of COPD", Eur Respir J, 33, pp.1165~1185 (2009)
- Chinitz JS, "Atrial fibrillation, stroke, and quality of life", Ann N Y Acad Sci, 1254, pp.140~150 (2012)
- Fuso L, "Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease", Am J Med, 98, pp.272~277 (1995)
- Steer J, "The decaf score: Predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease", Thorax, 67, pp.970~976 (2012)
- Ryynanen OP, "Bayesian predictors of very poor health related quality of life and mortality in patients with COPD", BMC Med Inform Decis Mak, 13, pp.34~ (2013)
- Olsson SB, "Atrial fibrillation--where do we stand today?", J Intern Med, 250, pp.19~28 (2001)
- Buch P, "Reduced lung function and risk of atrial fibrillation in the Copenhagen city heart study", Eur Respir J, 21, pp.1012~1016 (2003)
- Li J, "Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk In Communities (ARIC)study", Circulation, 129, pp.971~980 (2014)
- 24)Fuster V, "ACC", AHA, American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation), pp.Eur Heart J, 2006[DOI]
- Mandyam MC, "The QT interval and risk of incident atrial fibrillation", Heart rhythm, 10, pp.1562~1568 (2013)
- Nguyen KT, "The QT interval as a noninvasive marker of atrial refractoriness", Pacing and clinical electrophysiology, 39, pp.1366~1372 (2016)
- Stevenson IH, "Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea", Heart rhythm, 7, pp.1263~1270 (2010)
- Baum C, "Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general population", International journal of cardiology, 218, pp.298~304 (2016)
- Caram LM, "Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease", Clinics, 68, pp.772~776 (2013)
- Eweda I, "Concordance between Doppler and pulsedwave Doppler tissue imaging in estimation of the degree of left ventricular dysfunction and correlating it to the degree of chronic obstructive pulmonary disease", Journal of the Saudi Heart Association, 28, pp.15~21 (2016)
- Gan WQ, "Association between chronic obstructive pulmonary disease and systemic inflammation : a systematic review and a meta-analysis", Thorax, 59, pp.574~580 (2004)
- Harada M, "Role of inflammation in atrial fibrillation pathophysiology and management", Circ J, 79, pp.495~502 (2015)
- Huang CX, "Oxidative stress : a possible pathogenesis of atrial fibrillation", Medical hypotheses, 72, pp.466~467 (2009)
- Kirkham PA, "Oxidative stress in COPD", Chest, 144, pp.266~273 (2013)
- Wilchesky M, "Bronchodilator use and the risk of arrhythmia in COPD: part 2:reassessment in the larger Q uebec cohort", Chest, 142, pp.305~311 (2012)
- Cazzola M, "Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia", Chest, 114, pp.411~415 (1998)